Neutrophil CD11b, L-selectin and Fc IgA receptors in patients with dermatitis herpetiformis
Summary Background The skin lesions found in patients with dermatitis herpetiformis (DH) are characterized by the presence of neutrophils at the dermal papillary tips in areas where the diagnostic cutaneous IgA deposits are found. Although the presence of the skin lesions of DH is known to be assoc...
Saved in:
Published in | British journal of dermatology (1951) Vol. 147; no. 6; pp. 1109 - 1117 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Science Ltd
01.12.2002
Blackwell Oxford University Press |
Subjects | |
Online Access | Get full text |
ISSN | 0007-0963 1365-2133 |
DOI | 10.1046/j.1365-2133.2002.05004.x |
Cover
Loading…
Abstract | Summary Background The skin lesions found in patients with dermatitis herpetiformis (DH) are characterized by the presence of neutrophils at the dermal papillary tips in areas where the diagnostic cutaneous IgA deposits are found. Although the presence of the skin lesions of DH is known to be associated with gluten‐sensitive enteropathy, the mechanisms that control the development of skin lesions are not known.
Objectives To determine if circulating neutrophils from patients with DH have evidence of priming as shown by increased expression of CD11b, decreased expression of L‐selectin and increased function of neutrophil Fc IgA receptor.
Methods Neutrophils from 12 normal subjects and 10 DH patients with active, ongoing disease and 14 DH patients with quiescent disease activity were examined by fluorescence‐activated cell sorter for expression of cell surface CD11b, L‐selectin expression, Fc IgA expression (CD89) and for the function of the Fc IgA receptor by determining the binding capacity of neutrophils for monoclonal human IgA.
Results
Neutrophils from patients with active, ongoing DH had increased expression of CD11b when compared with patients with inactive DH or normal subjects [mean net geometric mean channel fluorescence (GMCF): active DH, 403·3; inactive DH, 237·8; normal subjects, 290·5;
P
< 0·05]. L‐selectin expression in both groups of DH patients was significantly lower than that seen in normal subjects (mean net GMCF: active DH, 363·2; inactive DH, 375·2; normal subjects, 432·7;
P < 0·05). No difference in CD89 expression was seen in any of the groups; however, the function of Fc IgA receptor was increased in patients with active DH when compared with patients with inactive DH and normal subjects.
Conclusions Neutrophils from patients with active, ongoing DH show an increased expression of CD11b, decreased expression of L‐selectin and increased ability to bind IgA, consistent with a pattern of priming of the neutrophils. This priming may occur in the gut as a result of the ongoing mucosal immune response that is present in patients with DH on a gluten‐containing diet and may predispose neutrophils to localize in the skin of patients with DH. |
---|---|
AbstractList | The skin lesions found in patients with dermatitis herpetiformis (DH) are characterized by the presence of neutrophils at the dermal papillary tips in areas where the diagnostic cutaneous IgA deposits are found. Although the presence of the skin lesions of DH is known to be associated with gluten-sensitive enteropathy, the mechanisms that control the development of skin lesions are not known.
To determine if circulating neutrophils from patients with DH have evidence of priming as shown by increased expression of CD11b, decreased expression of L-selectin and increased function of neutrophil Fc IgA receptor.
Neutrophils from 12 normal subjects and 10 DH patients with active, ongoing disease and 14 DH patients with quiescent disease activity were examined by fluorescence-activated cell sorter for expression of cell surface CD11b, L-selectin expression, Fc IgA expression (CD89) and for the function of the Fc IgA receptor by determining the binding capacity of neutrophils for monoclonal human IgA.
Neutrophils from patients with active, ongoing DH had increased expression of CD11b when compared with patients with inactive DH or normal subjects [mean net geometric mean channel fluorescence (GMCF): active DH, 403.3; inactive DH, 237.8; normal subjects, 290.5; P < 0.05]. L-selectin expression in both groups of DH patients was significantly lower than that seen in normal subjects (mean net GMCF: active DH, 363.2; inactive DH, 375.2; normal subjects, 432.7; P < 0.05). No difference in CD89 expression was seen in any of the groups; however, the function of Fc IgA receptor was increased in patients with active DH when compared with patients with inactive DH and normal subjects.
Neutrophils from patients with active, ongoing DH show an increased expression of CD11b, decreased expression of L-selectin and increased ability to bind IgA, consistent with a pattern of priming of the neutrophils. This priming may occur in the gut as a result of the ongoing mucosal immune response that is present in patients with DH on a gluten-containing diet and may predispose neutrophils to localize in the skin of patients with DH. Summary Background The skin lesions found in patients with dermatitis herpetiformis (DH) are characterized by the presence of neutrophils at the dermal papillary tips in areas where the diagnostic cutaneous IgA deposits are found. Although the presence of the skin lesions of DH is known to be associated with gluten‐sensitive enteropathy, the mechanisms that control the development of skin lesions are not known. Objectives To determine if circulating neutrophils from patients with DH have evidence of priming as shown by increased expression of CD11b, decreased expression of L‐selectin and increased function of neutrophil Fc IgA receptor. Methods Neutrophils from 12 normal subjects and 10 DH patients with active, ongoing disease and 14 DH patients with quiescent disease activity were examined by fluorescence‐activated cell sorter for expression of cell surface CD11b, L‐selectin expression, Fc IgA expression (CD89) and for the function of the Fc IgA receptor by determining the binding capacity of neutrophils for monoclonal human IgA. Results Neutrophils from patients with active, ongoing DH had increased expression of CD11b when compared with patients with inactive DH or normal subjects [mean net geometric mean channel fluorescence (GMCF): active DH, 403·3; inactive DH, 237·8; normal subjects, 290·5; P < 0·05]. L‐selectin expression in both groups of DH patients was significantly lower than that seen in normal subjects (mean net GMCF: active DH, 363·2; inactive DH, 375·2; normal subjects, 432·7; P < 0·05). No difference in CD89 expression was seen in any of the groups; however, the function of Fc IgA receptor was increased in patients with active DH when compared with patients with inactive DH and normal subjects. Conclusions Neutrophils from patients with active, ongoing DH show an increased expression of CD11b, decreased expression of L‐selectin and increased ability to bind IgA, consistent with a pattern of priming of the neutrophils. This priming may occur in the gut as a result of the ongoing mucosal immune response that is present in patients with DH on a gluten‐containing diet and may predispose neutrophils to localize in the skin of patients with DH. The skin lesions found in patients with dermatitis herpetiformis (DH) are characterized by the presence of neutrophils at the dermal papillary tips in areas where the diagnostic cutaneous IgA deposits are found. Although the presence of the skin lesions of DH is known to be associated with gluten-sensitive enteropathy, the mechanisms that control the development of skin lesions are not known.BACKGROUNDThe skin lesions found in patients with dermatitis herpetiformis (DH) are characterized by the presence of neutrophils at the dermal papillary tips in areas where the diagnostic cutaneous IgA deposits are found. Although the presence of the skin lesions of DH is known to be associated with gluten-sensitive enteropathy, the mechanisms that control the development of skin lesions are not known.To determine if circulating neutrophils from patients with DH have evidence of priming as shown by increased expression of CD11b, decreased expression of L-selectin and increased function of neutrophil Fc IgA receptor.OBJECTIVESTo determine if circulating neutrophils from patients with DH have evidence of priming as shown by increased expression of CD11b, decreased expression of L-selectin and increased function of neutrophil Fc IgA receptor.Neutrophils from 12 normal subjects and 10 DH patients with active, ongoing disease and 14 DH patients with quiescent disease activity were examined by fluorescence-activated cell sorter for expression of cell surface CD11b, L-selectin expression, Fc IgA expression (CD89) and for the function of the Fc IgA receptor by determining the binding capacity of neutrophils for monoclonal human IgA.METHODSNeutrophils from 12 normal subjects and 10 DH patients with active, ongoing disease and 14 DH patients with quiescent disease activity were examined by fluorescence-activated cell sorter for expression of cell surface CD11b, L-selectin expression, Fc IgA expression (CD89) and for the function of the Fc IgA receptor by determining the binding capacity of neutrophils for monoclonal human IgA.Neutrophils from patients with active, ongoing DH had increased expression of CD11b when compared with patients with inactive DH or normal subjects [mean net geometric mean channel fluorescence (GMCF): active DH, 403.3; inactive DH, 237.8; normal subjects, 290.5; P < 0.05]. L-selectin expression in both groups of DH patients was significantly lower than that seen in normal subjects (mean net GMCF: active DH, 363.2; inactive DH, 375.2; normal subjects, 432.7; P < 0.05). No difference in CD89 expression was seen in any of the groups; however, the function of Fc IgA receptor was increased in patients with active DH when compared with patients with inactive DH and normal subjects.RESULTSNeutrophils from patients with active, ongoing DH had increased expression of CD11b when compared with patients with inactive DH or normal subjects [mean net geometric mean channel fluorescence (GMCF): active DH, 403.3; inactive DH, 237.8; normal subjects, 290.5; P < 0.05]. L-selectin expression in both groups of DH patients was significantly lower than that seen in normal subjects (mean net GMCF: active DH, 363.2; inactive DH, 375.2; normal subjects, 432.7; P < 0.05). No difference in CD89 expression was seen in any of the groups; however, the function of Fc IgA receptor was increased in patients with active DH when compared with patients with inactive DH and normal subjects.Neutrophils from patients with active, ongoing DH show an increased expression of CD11b, decreased expression of L-selectin and increased ability to bind IgA, consistent with a pattern of priming of the neutrophils. This priming may occur in the gut as a result of the ongoing mucosal immune response that is present in patients with DH on a gluten-containing diet and may predispose neutrophils to localize in the skin of patients with DH.CONCLUSIONSNeutrophils from patients with active, ongoing DH show an increased expression of CD11b, decreased expression of L-selectin and increased ability to bind IgA, consistent with a pattern of priming of the neutrophils. This priming may occur in the gut as a result of the ongoing mucosal immune response that is present in patients with DH on a gluten-containing diet and may predispose neutrophils to localize in the skin of patients with DH. |
Author | Streilein, R.D. Smith, A.D. Hall III, R.P. |
Author_xml | – sequence: 1 givenname: A.D. surname: Smith fullname: Smith, A.D. organization: Division of Dermatology, Department of Medicine, Box 3135, Duke University Medical Center and Durham VA Medical Center, Durham, NC 27710, U.S.A – sequence: 2 givenname: R.D. surname: Streilein fullname: Streilein, R.D. organization: Division of Dermatology, Department of Medicine, Box 3135, Duke University Medical Center and Durham VA Medical Center, Durham, NC 27710, U.S.A – sequence: 3 givenname: R.P. surname: Hall III fullname: Hall III, R.P. organization: Division of Dermatology, Department of Medicine, Box 3135, Duke University Medical Center and Durham VA Medical Center, Durham, NC 27710, U.S.A |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14381634$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/12452859$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkUtv1DAUhS1URKeFv4AsJFiRYMevZEGlMu30oVGRENAFC8t17jAeMkmwHXX67-swQyt11ZWt6--ce33PAdpruxYQwpTklHD5aZVTJkVWUMbygpAiJ4IQnm9eoMnDwx6aEEJURirJ9tFBCCtCKEvgK7RPCy6KUlQT9OsKhui7fukaPD2h9OYjnmcBGrDRtdi0NZ5ZfPH7GHuw0MfOB5zqvYkO2hjwrYtLXINfp0J0AS_B9xDdovNrF16jlwvTBHizOw_Rj9np9-l5Nv96djE9nmeWS8IzaiTnlFXGUFUDYRLKVAFBF6JUBaNQF6rivAKljOLcEqaIBVGy9IuKS8YO0Yetb--7vwOEqFNzC01jWuiGoFWhqBC0SuC7J-CqG3ybZtNpi3T0Ugl6u4OGmzXUuvdubfyd_r-zBLzfASZY0yy8aa0LjxxnJZWMJ67cctZ3IXhYPCJEjzHqlR7T0mNa4wCF_hej3iTp0ROpdTGtuGujN655jsHnrcGta-Du2Y31l8uT8Zb02VbvQoTNg974P1oqpoS-vjrTM_Lz8lp-4_qc3QPzccFI |
CODEN | BJDEAZ |
CitedBy_id | crossref_primary_10_1016_j_det_2011_03_005 crossref_primary_10_1038_sj_jid_5700277 crossref_primary_10_1038_mi_2011_36 crossref_primary_10_3390_molecules30010113 crossref_primary_10_1111_j_1365_4632_2011_04996_x crossref_primary_10_1016_j_annder_2008_02_030 crossref_primary_10_1016_S1761_2896_11_71079_2 crossref_primary_10_1016_j_iac_2012_04_006 crossref_primary_10_1590_abd1806_4841_20131775 crossref_primary_10_1016_S1761_2896_22_46753_7 crossref_primary_10_3389_fimmu_2019_00553 crossref_primary_10_1155_2012_239691 crossref_primary_10_1038_sj_jid_5700929 crossref_primary_10_3389_fimmu_2021_657280 crossref_primary_10_1016_j_jdermsci_2003_11_004 crossref_primary_10_1172_JCI200421055 crossref_primary_10_1158_1078_0432_CCR_05_1434 crossref_primary_10_1155_2017_8980534 crossref_primary_10_3389_fimmu_2019_01290 crossref_primary_10_1111_eci_12716 crossref_primary_10_1016_j_actatropica_2021_105967 crossref_primary_10_1111_imr_12337 crossref_primary_10_1016_S0246_0319_11_56341_1 crossref_primary_10_3109_08916934_2011_606449 crossref_primary_10_1016_j_smim_2025_101941 crossref_primary_10_3390_ijms242015482 crossref_primary_10_2147_ITT_S266242 |
Cites_doi | 10.1111/1523-1747.ep12481904 10.1111/1523-1747.ep12614868 10.1097/00000372-198312000-00005 10.1016/S0016-5085(98)70007-1 10.1016/S0140-6736(67)91942-3 10.4049/jimmunol.159.10.5084 10.3109/10739689709146800 10.1016/0950-3528(95)90036-5 10.1016/0090-1229(92)90020-O 10.7326/0003-4819-93-6-857 10.1016/S0016-5085(98)70134-9 10.1016/S0140-6736(66)91692-8 10.1007/PL00007458 10.1023/A:1018887222296 10.1182/blood.V72.2.691.691 10.2165/00003088-198611040-00003 10.1111/1523-1747.ep12876246 10.1038/332647a0 10.1016/S0140-6736(94)92029-X 10.1023/A:1005489316037 10.1136/gut.35.10.1398 10.1023/A:1026699108147 10.1016/0092-8674(94)90337-9 10.4049/jimmunol.145.2.576 10.1042/cs0940461 10.1111/j.1365-2133.1982.tb00520.x 10.1097/00003246-199608000-00016 10.1056/NEJM198304073081406 10.1006/clim.2001.5007 10.1046/j.1365-2567.1996.d01-711.x |
ContentType | Journal Article |
Copyright | 2003 INIST-CNRS Copyright Blackwell Scientific Publications Ltd. Dec 2002 |
Copyright_xml | – notice: 2003 INIST-CNRS – notice: Copyright Blackwell Scientific Publications Ltd. Dec 2002 |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7T5 H94 K9. NAPCQ 7X8 |
DOI | 10.1046/j.1365-2133.2002.05004.x |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1365-2133 |
EndPage | 1117 |
ExternalDocumentID | 276947491 12452859 14381634 10_1046_j_1365_2133_2002_05004_x BJD5004 ark_67375_WNG_F0VJW6R4_H |
Genre | article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R01 AI047258 – fundername: NIAID NIH HHS grantid: 1R01 AI 47258-01A1 |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1CY 1OB 1OC 23N 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 5WD 66C 6P2 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AABZA AACZT AAESR AAEVG AAHHS AAONW AAPGJ AAPXW AARHZ AASGY AAUAY AAVAP AAWDT AAXRX AAZKR ABCQN ABCUV ABEJV ABEML ABNHQ ABOCM ABPTD ABPVW ABQNK ABWST ABXGK ABXVV ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACFRR ACGFS ACMXC ACPOU ACPRK ACSCC ACUTJ ACXBN ACXQS ACZBC ADBBV ADEOM ADIPN ADIZJ ADKYN ADMGS ADOZA ADQBN ADVEK ADXAS ADZMN ADZOD AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFEBI AFFNX AFGKR AFPWT AFYAG AFZJQ AGMDO AGQXC AGUTN AHEFC AIACR AIURR AIWBW AJAOE AJBDE AJEEA ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB APJGH ASPBG ATGXG ATUGU AVNTJ AVWKF AZBYB AZFZN AZVAB BAFTC BCRHZ BDRZF BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X H13 HF~ HVGLF HZI HZ~ IHE IX1 J0M J5H K48 KBYEO KOP L7B LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OAUYM OCZFY OIG OJZSN OPAEJ OVD OWPYF P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL ROX RX1 SUPJJ TEORI TMA UB1 V9Y VVN W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI X7M XG1 Y6R YFH ZGI ZXP ZZTAW ~IA ~WT AANHP ABDFA ACRPL ACYXJ ADNMO ADVOB AHMMS NU- AAYXX ABGNP ABJNI ABPQP ABVGC ACVCV ADMTO ADNBA AEMQT AFFQV AFXAL AGORE AGQPQ AHGBF AJBYB AJDVS AJNCP ALXQX CITATION OBFPC AAMMB AEFGJ AGXDD AIDQK AIDYY IQODW CGR CUY CVF ECM EIF NPM 7T5 H94 K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-c4604-1a644139aa17de036e8a64e51f587231ed279449e77a744c0370ce58312494633 |
IEDL.DBID | DR2 |
ISSN | 0007-0963 |
IngestDate | Fri Jul 11 11:44:50 EDT 2025 Fri Jul 25 04:58:32 EDT 2025 Wed Feb 19 02:33:52 EST 2025 Mon Jul 21 09:13:01 EDT 2025 Tue Jul 01 03:23:20 EDT 2025 Thu Apr 24 22:54:31 EDT 2025 Wed Jan 22 16:47:02 EST 2025 Wed Oct 30 09:51:22 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Bullous dermatosis Human Immunopathology Skin disease IgA Immune response Pathogenesis Granulocyte Fluorescence Autoimmune disease Dermatitis herpetiformis L Selectin CDllb Neutrophil ELISA assay neutrophils Comparative study Biological receptor mucosal immunity |
Language | English |
License | http://doi.wiley.com/10.1002/tdm_license_1.1 CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4604-1a644139aa17de036e8a64e51f587231ed279449e77a744c0370ce58312494633 |
Notes | istex:39FF84E04482B9387328AF34FD9DD9485CA44180 ark:/67375/WNG-F0VJW6R4-H ArticleID:BJD5004 ObjectType-Article-1 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-2 content type line 23 |
PMID | 12452859 |
PQID | 200146337 |
PQPubID | 36393 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_72715519 proquest_journals_200146337 pubmed_primary_12452859 pascalfrancis_primary_14381634 crossref_primary_10_1046_j_1365_2133_2002_05004_x crossref_citationtrail_10_1046_j_1365_2133_2002_05004_x wiley_primary_10_1046_j_1365_2133_2002_05004_x_BJD5004 istex_primary_ark_67375_WNG_F0VJW6R4_H |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | December 2002 |
PublicationDateYYYYMMDD | 2002-12-01 |
PublicationDate_xml | – month: 12 year: 2002 text: December 2002 |
PublicationDecade | 2000 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: London – name: Oxford – name: Edinburgh – name: England |
PublicationTitle | British journal of dermatology (1951) |
PublicationTitleAlternate | Br J Dermatol |
PublicationYear | 2002 |
Publisher | Blackwell Science Ltd Blackwell Oxford University Press |
Publisher_xml | – name: Blackwell Science Ltd – name: Blackwell – name: Oxford University Press |
References | Katz SI, Hall RP III, Lawley TJ, Strober W. Dermatitis herpetiformis: the skin and the gut. Ann Intern Med 1980; 93: 857-74. Ward MM, Pisetsky DS, Hall RP III. Soluble interleukin-2 receptor levels in patients with dermatitis herpetiformis. J Invest Dermatol 1991; 97: 568-72. Hansbrough JF, Wikstrom T, Braide M et al. Effects of E-selectin and P-selectin blockade on neutrophil sequestration in tissues and neutrophil oxidative burst in burned rats. Crit Care Med 1996; 24: 1366-72. Fry L, Leonard JN, Swain F et al. Long term follow-up of dermatitis herpetiformis with and without dietary gluten withdrawal. Br J Dermatol 1982; 107: 631-40. Bernstein CN, Sargent M, Rawsthorne P et al. Peripheral blood lymphocyte β2 integrin and ICAM expression in inflammatory bowel disease. Dig Dis Sci 1997; 42: 2338-49. Jelinkova L, Tuckova L, Sanchez D et al. Increased levels of circulating ICAM-1, E-selectin, and IL-2 receptors in celiac disease. Dig Dis Sci 2000; 45: 398-402. Condliffe AM, Kitchen E, Chilvers ER. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin Sci 1998; 94: 461-71. Weisbart RH, Kacena A, Schuh A et al. GM-CSF induces human neutrophil IgA mediated phagocytosis by an IgA Fc receptor activation mechanism. Nature 1988; 332: 647-8. Hall RP III Dermatitis herpetiformis. J Invest Dermatol 1992; 99: 873-81. Zuidema J, Hilbers-Modderman ESM, Merkus FWHM. Clinical pharmacokinetics of dapsone. Clin Pharmacokinetics 1986; 11: 299-315. Dieterich W, Laag E, Schopper H et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998; 115: 1317-21. Burg ND, Pillinger MH. The neutrophil: function and regulation in innate and humoral immunity. Clin Immunol 2001; 99: 7-17. Xiao F, Eppihimer MJ, Young JA et al. Lung neutrophil retention and injury after intestinal ischemia/reperfusion. Microcirculation 1997; 4: 359-67. Lee RT, Briggs WH, Cheng GC et al. Mechanical deformation promotes secretion of IL-1alpha and IL-1 receptor antagonist. J Immunol 1997; 159: 5084-8. Brown E. Neutrophil adhesion and the therapy of inflammation. Semin Hematol 1997; 34: 319-26. Nilsen EM, Jahnsen FL, Lundin KEA et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998; 115: 551-33. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301-14. Modschiedler K, Weller M, Worl P et al. Dapsone and colchicine inhibit adhesion of neutrophilic granulocytes to epidermal sections. Arch Dermatol Res 2000; 292: 32-6. Adams DH, Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 1994; 343: 831-6. Fry L, Keir P, McMinn RMH. Small-intestinal structure and function and haematological changes in dermatitis herpetiformis. Lancet 1967; ii: 729-33. Griffin JD, Spertini O, Ernst TJ et al. Granulocyte-macrophage colony-stimulating factor and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophils, monocytes and their precursors. J Immunol 1990; 145: 576-84. Marks J, Shuster S, Watson AJ. Small-bowel changes in dermatitis herpetiformis. Lancet 1966; ii: 1280-2. Blenkinsopp WK, Haffenden GP, Fry L et al. Histology of linear IgA disease, dermatitis herpetiformis, and bullous pemphigoid. Am J Dermatopathol 1983; 5: 547-54. Smith AD, Bagheri B, Streilein RD et al. Expression of interleukin-4 and interferon-γ in the small bowel of patients with dermatitis herpetiformis and isolated gluten-sensitive enteropathy. Dig Dis Sci 1999; 44: 2124-32. Przemioslo RT, Kontakou M, Nobili V et al. Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor α in coeliac disease mucosa detected by immunohistochemistry. Gut 1994; 35: 1398-403. Crabtree JE, Heatley RV, Juby LD et al. Soluble interleukin-2 receptor in coeliac disease: response to treatment and gluten challenge. Clin Exp Immunol 1989; 77: 345-8. Fry L. Dermatitis herpetiformis. Baillieres Clin Gastroenterol 1995; 9: 371-93. Leonard J, Haffenden G, Tucker W et al. Gluten challenge in dermatitis herpetiformis. N Engl J Med 1983; 308: 816-19. Condliffe AM, Chilvers ER, Haslett C, Dransfield I. Priming differentially regulates neutrophil adhesion molecule expression/function. Immunology 1996; 89: 105-11. Socinski MA, Cannistra SA, Sullivan R et al. Granulocyte-macrophage colony-stimulating factor induces the expression of the CD11b surface adhesion molecule on human granulocytes in vivo. Blood 1988; 72: 691-7. Hall RP III, McKenzie KD. Comparison of the intestinal and serum antibody response in patients with dermatitis herpetiformis. Clin Immunol Immunopathol 1997; 62: 33-41. Hendrix JD, Mangum KL, Zone JJ et al. Cutaneous IgA deposits in bullous diseases function as ligands to mediate adherence of activated neutrophils. J Invest Dermatol 1990; 94: 667-72. 1995; 9 1997; 159 1997; 62 2000; 45 1997; 42 1982; 107 1986; 11 1991; 97 1983; 5 2000; 292 1996 1999; 44 1988; 72 1998; 115 1980; 93 1990; 145 1992; 99 1966; ii 1997; 4 1994; 343 1989; 77 1967; ii 1997; 34 1988; 332 1994; 35 1998; 94 2001; 99 1996; 24 1983; 308 1994; 76 1996; 89 1990; 94 Przemioslo RT (b27_204) 1994; 35 b30_207 Fry L (b6_183) 1982; 107 Condliffe AM (b13_190) 1998; 94 b14_191 Fry L (b3_180) 1995; 9 Socinski MA (b11_188) 1988; 72 b9_186 Crabtree JE (b29_206) 1989; 77 Hall RP (b16_193) 1997; 62 b22_199 Xiao F (b23_200) 1997; 4 b10_187 Leonard J (b7_184) 1983; 308 Hendrix JD (b19_196) 1990; 94 Ward MM (b28_205) 1991; 97 Hansbrough JF (b24_201) 1996; 24 Smith AD (b25_202) 1999; 44 Lee RT (b21_198) 1997; 159 Keogh M (b2_179) 1996 b5_182 Modschiedler K (b32_209) 2000; 292 Dieterich W (b15_192) 1998; 115 Brown E (b8_185) 1997; 34 b31_208 Zuidema J (b33_210) 1986; 11 b20_197 Blenkinsopp WK (b18_195) 1983; 5 Hall RP (b1_178) 1992; 99 Katz SI (b17_194) 1980; 93 b4_181 Griffin JD (b12_189) 1990; 145 Nilsen EM (b26_203) 1998; 115 |
References_xml | – reference: Przemioslo RT, Kontakou M, Nobili V et al. Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor α in coeliac disease mucosa detected by immunohistochemistry. Gut 1994; 35: 1398-403. – reference: Hendrix JD, Mangum KL, Zone JJ et al. Cutaneous IgA deposits in bullous diseases function as ligands to mediate adherence of activated neutrophils. J Invest Dermatol 1990; 94: 667-72. – reference: Bernstein CN, Sargent M, Rawsthorne P et al. Peripheral blood lymphocyte β2 integrin and ICAM expression in inflammatory bowel disease. Dig Dis Sci 1997; 42: 2338-49. – reference: Marks J, Shuster S, Watson AJ. Small-bowel changes in dermatitis herpetiformis. Lancet 1966; ii: 1280-2. – reference: Adams DH, Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 1994; 343: 831-6. – reference: Hall RP III, McKenzie KD. Comparison of the intestinal and serum antibody response in patients with dermatitis herpetiformis. Clin Immunol Immunopathol 1997; 62: 33-41. – reference: Xiao F, Eppihimer MJ, Young JA et al. Lung neutrophil retention and injury after intestinal ischemia/reperfusion. Microcirculation 1997; 4: 359-67. – reference: Katz SI, Hall RP III, Lawley TJ, Strober W. Dermatitis herpetiformis: the skin and the gut. Ann Intern Med 1980; 93: 857-74. – reference: Blenkinsopp WK, Haffenden GP, Fry L et al. Histology of linear IgA disease, dermatitis herpetiformis, and bullous pemphigoid. Am J Dermatopathol 1983; 5: 547-54. – reference: Brown E. Neutrophil adhesion and the therapy of inflammation. Semin Hematol 1997; 34: 319-26. – reference: Condliffe AM, Chilvers ER, Haslett C, Dransfield I. Priming differentially regulates neutrophil adhesion molecule expression/function. Immunology 1996; 89: 105-11. – reference: Dieterich W, Laag E, Schopper H et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998; 115: 1317-21. – reference: Jelinkova L, Tuckova L, Sanchez D et al. Increased levels of circulating ICAM-1, E-selectin, and IL-2 receptors in celiac disease. Dig Dis Sci 2000; 45: 398-402. – reference: Ward MM, Pisetsky DS, Hall RP III. Soluble interleukin-2 receptor levels in patients with dermatitis herpetiformis. J Invest Dermatol 1991; 97: 568-72. – reference: Condliffe AM, Kitchen E, Chilvers ER. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin Sci 1998; 94: 461-71. – reference: Fry L, Leonard JN, Swain F et al. Long term follow-up of dermatitis herpetiformis with and without dietary gluten withdrawal. Br J Dermatol 1982; 107: 631-40. – reference: Weisbart RH, Kacena A, Schuh A et al. GM-CSF induces human neutrophil IgA mediated phagocytosis by an IgA Fc receptor activation mechanism. Nature 1988; 332: 647-8. – reference: Hansbrough JF, Wikstrom T, Braide M et al. Effects of E-selectin and P-selectin blockade on neutrophil sequestration in tissues and neutrophil oxidative burst in burned rats. Crit Care Med 1996; 24: 1366-72. – reference: Smith AD, Bagheri B, Streilein RD et al. Expression of interleukin-4 and interferon-γ in the small bowel of patients with dermatitis herpetiformis and isolated gluten-sensitive enteropathy. Dig Dis Sci 1999; 44: 2124-32. – reference: Crabtree JE, Heatley RV, Juby LD et al. Soluble interleukin-2 receptor in coeliac disease: response to treatment and gluten challenge. Clin Exp Immunol 1989; 77: 345-8. – reference: Zuidema J, Hilbers-Modderman ESM, Merkus FWHM. Clinical pharmacokinetics of dapsone. Clin Pharmacokinetics 1986; 11: 299-315. – reference: Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301-14. – reference: Hall RP III Dermatitis herpetiformis. J Invest Dermatol 1992; 99: 873-81. – reference: Modschiedler K, Weller M, Worl P et al. Dapsone and colchicine inhibit adhesion of neutrophilic granulocytes to epidermal sections. Arch Dermatol Res 2000; 292: 32-6. – reference: Burg ND, Pillinger MH. The neutrophil: function and regulation in innate and humoral immunity. Clin Immunol 2001; 99: 7-17. – reference: Nilsen EM, Jahnsen FL, Lundin KEA et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998; 115: 551-33. – reference: Fry L, Keir P, McMinn RMH. Small-intestinal structure and function and haematological changes in dermatitis herpetiformis. Lancet 1967; ii: 729-33. – reference: Lee RT, Briggs WH, Cheng GC et al. Mechanical deformation promotes secretion of IL-1alpha and IL-1 receptor antagonist. J Immunol 1997; 159: 5084-8. – reference: Griffin JD, Spertini O, Ernst TJ et al. Granulocyte-macrophage colony-stimulating factor and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophils, monocytes and their precursors. J Immunol 1990; 145: 576-84. – reference: Leonard J, Haffenden G, Tucker W et al. Gluten challenge in dermatitis herpetiformis. N Engl J Med 1983; 308: 816-19. – reference: Fry L. Dermatitis herpetiformis. Baillieres Clin Gastroenterol 1995; 9: 371-93. – reference: Socinski MA, Cannistra SA, Sullivan R et al. Granulocyte-macrophage colony-stimulating factor induces the expression of the CD11b surface adhesion molecule on human granulocytes in vivo. Blood 1988; 72: 691-7. – volume: ii start-page: 729 year: 1967 end-page: 33 article-title: Small‐intestinal structure and function and haematological changes in dermatitis herpetiformis publication-title: Lancet – volume: 42 start-page: 2338 year: 1997 end-page: 49 article-title: Peripheral blood lymphocyte β2 integrin and ICAM expression in inflammatory bowel disease publication-title: Dig Dis Sci – volume: 99 start-page: 7 year: 2001 end-page: 17 article-title: The neutrophil: function and regulation in innate and humoral immunity publication-title: Clin Immunol – volume: 159 start-page: 5084 year: 1997 end-page: 8 article-title: Mechanical deformation promotes secretion of IL‐1alpha and IL‐1 receptor antagonist publication-title: J Immunol – volume: 77 start-page: 345 year: 1989 end-page: 8 article-title: Soluble interleukin‐2 receptor in coeliac disease: response to treatment and gluten challenge publication-title: Clin Exp Immunol – volume: 76 start-page: 301 year: 1994 end-page: 14 article-title: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm publication-title: Cell – volume: 24 start-page: 1366 year: 1996 end-page: 72 article-title: Effects of E‐selectin and P‐selectin blockade on neutrophil sequestration in tissues and neutrophil oxidative burst in burned rats publication-title: Crit Care Med – volume: 9 start-page: 371 year: 1995 end-page: 93 article-title: Dermatitis herpetiformis publication-title: Baillieres Clin Gastroenterol – volume: 34 start-page: 319 year: 1997 end-page: 26 article-title: Neutrophil adhesion and the therapy of inflammation publication-title: Semin Hematol – volume: 99 start-page: 873 year: 1992 end-page: 81 article-title: Dermatitis herpetiformis publication-title: J Invest Dermatol – volume: 72 start-page: 691 year: 1988 end-page: 7 article-title: Granulocyte‐macrophage colony‐stimulating factor induces the expression of the CD11b surface adhesion molecule on human granulocytes publication-title: Blood – volume: 115 start-page: 551 year: 1998 end-page: 33 article-title: Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease publication-title: Gastroenterology – volume: 97 start-page: 568 year: 1991 end-page: 72 article-title: Soluble interleukin‐2 receptor levels in patients with dermatitis herpetiformis publication-title: J Invest Dermatol – volume: 62 start-page: 33 year: 1997 end-page: 41 article-title: Comparison of the intestinal and serum antibody response in patients with dermatitis herpetiformis publication-title: Clin Immunol Immunopathol – volume: 94 start-page: 667 year: 1990 end-page: 72 article-title: Cutaneous IgA deposits in bullous diseases function as ligands to mediate adherence of activated neutrophils publication-title: J Invest Dermatol – volume: 11 start-page: 299 year: 1986 end-page: 315 article-title: Clinical pharmacokinetics of dapsone publication-title: Clin Pharmacokinetics – volume: 4 start-page: 359 year: 1997 end-page: 67 article-title: Lung neutrophil retention and injury after intestinal ischemia/reperfusion publication-title: Microcirculation – volume: 5 start-page: 547 year: 1983 end-page: 54 article-title: Histology of linear IgA disease, dermatitis herpetiformis, and bullous pemphigoid publication-title: Am J Dermatopathol – volume: 332 start-page: 647 year: 1988 end-page: 8 article-title: GM‐CSF induces human neutrophil IgA mediated phagocytosis by an IgA Fc receptor activation mechanism publication-title: Nature – volume: ii start-page: 1280 year: 1966 end-page: 2 article-title: Small‐bowel changes in dermatitis herpetiformis publication-title: Lancet – volume: 93 start-page: 857 year: 1980 end-page: 74 article-title: Dermatitis herpetiformis: the skin and the gut publication-title: Ann Intern Med – volume: 44 start-page: 2124 year: 1999 end-page: 32 article-title: Expression of interleukin‐4 and interferon‐γ in the small bowel of patients with dermatitis herpetiformis and isolated gluten‐sensitive enteropathy publication-title: Dig Dis Sci – volume: 292 start-page: 32 year: 2000 end-page: 6 article-title: Dapsone and colchicine inhibit adhesion of neutrophilic granulocytes to epidermal sections publication-title: Arch Dermatol Res – volume: 107 start-page: 631 year: 1982 end-page: 40 article-title: Long term follow‐up of dermatitis herpetiformis with and without dietary gluten withdrawal publication-title: Br J Dermatol – volume: 308 start-page: 816 year: 1983 end-page: 19 article-title: Gluten challenge in dermatitis herpetiformis publication-title: N Engl J Med – start-page: 691 year: 1996 end-page: 7 – volume: 45 start-page: 398 year: 2000 end-page: 402 article-title: Increased levels of circulating ICAM‐1, E‐selectin, and IL‐2 receptors in celiac disease publication-title: Dig Dis Sci – volume: 343 start-page: 831 year: 1994 end-page: 6 article-title: Leucocyte–endothelial interactions and regulation of leucocyte migration publication-title: Lancet – volume: 35 start-page: 1398 year: 1994 end-page: 403 article-title: Raised pro‐inflammatory cytokines interleukin 6 and tumour necrosis factor α in coeliac disease mucosa detected by immunohistochemistry publication-title: Gut – volume: 89 start-page: 105 year: 1996 end-page: 11 article-title: Priming differentially regulates neutrophil adhesion molecule expression/function publication-title: Immunology – volume: 94 start-page: 461 year: 1998 end-page: 71 article-title: Neutrophil priming: pathophysiological consequences and underlying mechanisms publication-title: Clin Sci – volume: 115 start-page: 1317 year: 1998 end-page: 21 article-title: Autoantibodies to tissue transglutaminase as predictors of celiac disease publication-title: Gastroenterology – volume: 145 start-page: 576 year: 1990 end-page: 84 article-title: Granulocyte‐macrophage colony‐stimulating factor and other cytokines regulate surface expression of the leukocyte adhesion molecule‐1 on human neutrophils, monocytes and their precursors publication-title: J Immunol – volume: 97 start-page: 568 year: 1991 ident: b28_205 publication-title: J Invest Dermatol doi: 10.1111/1523-1747.ep12481904 – volume: 99 start-page: 873 year: 1992 ident: b1_178 publication-title: J Invest Dermatol doi: 10.1111/1523-1747.ep12614868 – start-page: 691 volume-title: Cutaneous Medicine and Surgery year: 1996 ident: b2_179 – volume: 5 start-page: 547 year: 1983 ident: b18_195 publication-title: Am J Dermatopathol doi: 10.1097/00000372-198312000-00005 – volume: 115 start-page: 1317 year: 1998 ident: b15_192 publication-title: Gastroenterology doi: 10.1016/S0016-5085(98)70007-1 – ident: b5_182 doi: 10.1016/S0140-6736(67)91942-3 – volume: 159 start-page: 5084 year: 1997 ident: b21_198 publication-title: J Immunol doi: 10.4049/jimmunol.159.10.5084 – volume: 4 start-page: 359 year: 1997 ident: b23_200 publication-title: Microcirculation doi: 10.3109/10739689709146800 – volume: 9 start-page: 371 year: 1995 ident: b3_180 publication-title: Baillieres Clin Gastroenterol doi: 10.1016/0950-3528(95)90036-5 – volume: 62 start-page: 33 year: 1997 ident: b16_193 publication-title: Clin Immunol Immunopathol doi: 10.1016/0090-1229(92)90020-O – volume: 93 start-page: 857 year: 1980 ident: b17_194 publication-title: Ann Intern Med doi: 10.7326/0003-4819-93-6-857 – volume: 115 start-page: 551 year: 1998 ident: b26_203 publication-title: Gastroenterology doi: 10.1016/S0016-5085(98)70134-9 – ident: b4_181 doi: 10.1016/S0140-6736(66)91692-8 – volume: 292 start-page: 32 year: 2000 ident: b32_209 publication-title: Arch Dermatol Res doi: 10.1007/PL00007458 – ident: b31_208 doi: 10.1023/A:1018887222296 – volume: 72 start-page: 691 year: 1988 ident: b11_188 publication-title: Blood doi: 10.1182/blood.V72.2.691.691 – volume: 11 start-page: 299 year: 1986 ident: b33_210 publication-title: Clin Pharmacokinetics doi: 10.2165/00003088-198611040-00003 – volume: 94 start-page: 667 year: 1990 ident: b19_196 publication-title: J Invest Dermatol doi: 10.1111/1523-1747.ep12876246 – ident: b20_197 doi: 10.1038/332647a0 – volume: 77 start-page: 345 year: 1989 ident: b29_206 publication-title: Clin Exp Immunol – ident: b10_187 doi: 10.1016/S0140-6736(94)92029-X – ident: b30_207 doi: 10.1023/A:1005489316037 – volume: 35 start-page: 1398 year: 1994 ident: b27_204 publication-title: Gut doi: 10.1136/gut.35.10.1398 – volume: 44 start-page: 2124 year: 1999 ident: b25_202 publication-title: Dig Dis Sci doi: 10.1023/A:1026699108147 – ident: b9_186 doi: 10.1016/0092-8674(94)90337-9 – volume: 145 start-page: 576 year: 1990 ident: b12_189 publication-title: J Immunol doi: 10.4049/jimmunol.145.2.576 – volume: 94 start-page: 461 year: 1998 ident: b13_190 publication-title: Clin Sci doi: 10.1042/cs0940461 – volume: 107 start-page: 631 year: 1982 ident: b6_183 publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.1982.tb00520.x – volume: 24 start-page: 1366 year: 1996 ident: b24_201 publication-title: Crit Care Med doi: 10.1097/00003246-199608000-00016 – volume: 308 start-page: 816 year: 1983 ident: b7_184 publication-title: N Engl J Med doi: 10.1056/NEJM198304073081406 – ident: b14_191 doi: 10.1006/clim.2001.5007 – volume: 34 start-page: 319 year: 1997 ident: b8_185 publication-title: Semin Hematol – ident: b22_199 doi: 10.1046/j.1365-2567.1996.d01-711.x |
SSID | ssj0013050 |
Score | 1.8597417 |
Snippet | Summary Background The skin lesions found in patients with dermatitis herpetiformis (DH) are characterized by the presence of neutrophils at the dermal... The skin lesions found in patients with dermatitis herpetiformis (DH) are characterized by the presence of neutrophils at the dermal papillary tips in areas... |
SourceID | proquest pubmed pascalfrancis crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1109 |
SubjectTerms | Adult Aged Aged, 80 and over Antigens, CD - blood Biological and medical sciences Bullous diseases of the skin CD11b CD11b Antigen - blood dermatitis herpetiformis Dermatitis Herpetiformis - immunology Dermatology Female Humans Immunity, Mucosal Immunoglobulin A - metabolism L-Selectin - blood Male Medical sciences Middle Aged mucosal immunity Neutrophil Activation neutrophils Neutrophils - immunology Receptors, Fc - blood Receptors, Fc - metabolism |
Title | Neutrophil CD11b, L-selectin and Fc IgA receptors in patients with dermatitis herpetiformis |
URI | https://api.istex.fr/ark:/67375/WNG-F0VJW6R4-H/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1046%2Fj.1365-2133.2002.05004.x https://www.ncbi.nlm.nih.gov/pubmed/12452859 https://www.proquest.com/docview/200146337 https://www.proquest.com/docview/72715519 |
Volume | 147 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbhMxFLVQKyE2UN5DH3iBWDGRnfFjsuyDECKaRUVpN8jyeDwlSjWJMolUseIT-Ea-pPd6ZhIFdVEhdiNb9sjX1_ax7-MQ8o5Jm1rfE3A3UXksUs_i1Kki5qpwCgm7E4mxw6cjNTgXw0t52fg_YSxMnR9i9eCGKyPs17jAbVazkLCQ3bb10IJLVvA06DAJE95BPIkViI_OumuDApN1NAq-zIHSNU49jYHzzo42TqptFPoNek7aCoRX1KwXd8HSTZQbjqn-EzJpB1h7p0w6y0XWcT__yv34fySwQx43aJYe1ur3lDzw5TPy8LSx1z8n30d-uZhPZz_G1_T4hPPsA_3y59fvKpDvjEtqy5z2Hf18dUhh5_UzpP6hUN5ke60oPhPT3Ne4elxR0DCA-RhNBvr5gpz3P349HsQNoUPshML8iBbRV9Kzluvcw9npUyjxkhcy1QA0fd6F7UH0vNZWC-FYopnzMk2QIVuoJHlJtspp6V8T6pwU3SzD5PxMaJdYCxddnuiscD7NnI2IbifPuCbbOZJuXJtgdRcYoYbSMyg95OLsmiA9cxMRvmo5qzN-3KPN-6AfqwZ2PkGPOS3NxeiT6bNvwwt1JswgIgcbCrT-A6ZaU4mIyG6rUabZTSr8Fcfh64i8XdWCmNG2Y0s_XVYGYCiC315EXtVquO4ZbeuphBoVlOnegzJHwxP8evOvDXfJo5Y7h_E9srWYL_0-QLhFdhAW5y3k3jJw |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9MwFLfQJg0uwPgYYWzzAXEiJWn8kR7HutKVtodpY7sgy3EcqFalVdNKEyf-BP5G_hLec9xWRTtMiFvkyLH88p79s9_Hj5C3Edepti0GZxORhyy1UZgaUYSxKIxAwu6EY-7wYCi6l6x3za89HRDmwtT1IVYXbmgZbr1GA8cL6Q_eLVlbuQvRglOWCzVoRBz-eAMA5TYSfKOVts-ba5dCxOt8FLybA7XzYT3exXnnlzb2qm0U-y3GTuoKxFfUvBd3AdNNnOs2qs4TMl5OsY5PuWks5lnD_Pir-uN_ksFT8tgDWnpca-AueWDLZ2Rn4F32z8nXoV3MZ5Pp99GYnrTjOHtP-79__qoc_86opLrMacfQs2_HFBZfO0X2HwrtvuBrRfGmmOa2htajioKSAdLHhDJQ0RfksnN6cdINPadDaJjAEokaAVjS0jqWuYXt06bQYnlc8FQC1rR5E1YI1rJSasmYiRIZGcvTBEmymUiSl2SrnJT2FaHGcNbMMqzPHzFpEq3hrBsnMiuMTTOjAyKXf08ZX_AceTfGyjneGSapofQUSg_pOJvKSU_dBiRe9ZzWRT_u0eedU5BVBz27waA5ydXV8JPqRF96V-KcqW5ADjc0aD0CVlsTCQvI_lKllF9QKhwqxunLgByt3oKY0b2jSztZVAqQKOLfVkD2aj1cfxnd6ymHN8Jp070npT722vj0-l87HpGH3YtBX_XPhp_3yaMllU4UvyFb89nCHgCim2eHzlL_AAxfNok |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9MwGLbQJk1c-IaFweYD4kSK0_gjPY6V0pWtQhNjuyDLcRyoOqVV00oTJ34Cv5Ffwvs6bquiHSbELXJkW3792H7s94uQV0yYzLgOh7uJLGKeORZnVpZxIksrMWF3KtB3-HQo--d8cCkug_0T-sI08SFWD264Mvx-jQt8WpRvg1ayWeTeQgsuWd7SoMUETHgL-OQ2lyzDi1j3rL3WKDDRuKPg0xygLlj1BA3njS1tHFXbKPVrNJ00NUivbNJe3MRLN2muP6d698l4OcLGPGXcWszzlv3xV_DH_yOCB-ReoLP0sMHfQ3LHVY_IzmlQ2D8mX4duMZ9Npt9HV_SomyT5G3ry--ev2mffGVXUVAXtWXr87ZDC1uummPuHQnkI91pTfCemhWuI9aimADHg-ehOBgB9Qs577z8f9eOQ0SG2MCc8TgzSr7RjTKIKB4eny6DEiaQUmQKm6Yo27A-845QyinPLUsWsE1mKKbK5TNOnZKuaVG6XUGsFb-c5RudnXNnUGLjpJqnKS-uy3JqIqOXkaRvCnWPWjSvt1e4cXdRQehqlh8k429pLT19HJFnVnDYhP25R57XHx6qCmY3RZE4JfTH8oHvsy-BCnnHdj8j-BoDWPWCsNZnyiOwtEaXDdlJjVwkOX0XkYPUXxIzKHVO5yaLWwEOR_XYi8qyB4bplVK5nAv5ID6ZbD0q_G3Tx6_m_VjwgO5-6PX1yPPy4R-4u8-iw5AXZms8W7iXQuXm-79fpH0FDNUE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neutrophil+CD11b%2C+L-selectin+and+Fc+IgA+receptors+in+patients+with+dermatitis+herpetiformis&rft.jtitle=British+journal+of+dermatology+%281951%29&rft.au=Smith%2C+A+D&rft.au=Streilein%2C+R+D&rft.au=Hall%2C+3rd%2C+R+P&rft.date=2002-12-01&rft.issn=0007-0963&rft.volume=147&rft.issue=6&rft.spage=1109&rft_id=info:doi/10.1046%2Fj.1365-2133.2002.05004.x&rft_id=info%3Apmid%2F12452859&rft.externalDocID=12452859 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-0963&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-0963&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-0963&client=summon |